Althea Foster  
  Althea Foster is one of the foremost podiatrists involved in the management of the diabetic foot.She belongs to Kings College London and has played a major role inpopularising basic foot care for diabetes.She conducted a comprehensive live workshop on management of the diabetic foot on July 15th, 2008.  
     
 
 
     
  Allan Arthur Vaag  
 
Present position(s):
01.08.2001- Chief Physician, Steno Diabetes Center, Gentofte, Denmark.
01.01.2005 – Adjunct Professor of Metabolism and Clinical Diabetes Research, Lund University, Sweden
Research Interest : Low Birth weight and foetal orgin of Diabetes and has over 100 Publications . He visited the Department on January 2007.
 
     
  Prof .Ajith Varki  
 
Ajit Varki is currently Professor in the Departments of Medicine and Cellular & Molecular Medicine, Co-Director of the Glycobiology Research and Training Center, and Associate Dean for Physician-Scientist Training at the University of California, San Diego (UCSD). He received basic training in Physiology, Medicine, Biology, and Biochemistry at the Christian Medical College, Vellore, The University of Nebraska,
 
  and Washington University in St. Louis. He also has training and board certification in internal medicine, hematology, and oncology. Dr.Varki is Executive Editor of the textbook "Essentials of a MERIT award from the NIH, and an American Cancer Society Faculty Research Award. He is an elected member of the American Academy of Arts and Sciences, the American Society for Clinical Investigation, and the Association of American Physicians. Significant past appointments include: Co-Head, UCSD Division of Hematology-Oncology (1987-89); President of the Society for Glycobiology (1996); Editor-in-Chief of the Journal of Clinical Investigation (1992-97); Interim Directorship of the UCSD Cancer Center (1996-1997), and President of the American Society for Clinical Investigation (1998-1999). Dr. Varki's research interests are focused on a family of cell surface sugars called the Sialic Acids, and their roles in biology, evolution and disease. Currently active projects are relevant to the roles of sialic acids in microbial infectivity, the regulation of the immune response, the progression and spread of tumors, and, unique aspects of human evolution. His group is particularly intrigued in finding multiple differences in sialic acid biology between humans and our closest evolutionary cousins, the great apes. These differences are a signature of the events that occurred during the last few million years of human evolution, and appear relevant to understanding several aspects of the current human condition, both in health and disease. He visited the Department on January 2007.  
     
  Prof. Andrew J Boulton, MD, DSc (hon), FRCP  
 
Professor Boulton graduated (with honors) from the University of Newcastle-upon-Tyne Medical School. He was subsequently a research fellow under Professor JD Ward in Sheffield, and Visiting Assistant Professor at the University of Miami prior to accepting an appointment at the Manchester Royal Infirmary. Professor Boulton has authored more than 350 peer-reviewed manuscripts and book chapters,
 
  mainly on diabetic neuropathy and foot complications. He was the principal invited lecturer at the launch of the American Diabetes Association's Foot Care Council. Among his many awards, his contribution to worldwide care of the diabetic foot was honored by receiving the American Diabetes Association's Roger Pecoraro Lectureship, the EASD Camillo Golgi prize and was the first recipient of the international award on diabetic foot research  
 
         He was the founding Chairman of the Diabetic Foot Study Group was previously Chairman of Postgraduate Education and then program chair for the European Association for the Study of Diabetes (EASD). He is currently director of extra-European postgraduate education and training for the EASD.
He visited the Department on January 2007.
  
     
  Prof. Ashley Grossman  
 
Ashley Grossman initially graduated with a BA in Psychology and Social Anthropology from the University of London, then entered University College Hospital Medical School in London and took the University Gold Medal in 1975. He also obtained a BSc in Neuroscience. Following junior posts in cardiology and neurology; he joined the Department of Endocrinology at St. Bartholomew's Hospital
 
 
where he has been for the past 28 years, and where he is currently Professor of Neuroendocrinology and Consultant Physician In 2000 he was appointed a fellow of the Academy of Medical Sciences. He has published over 500 research papers and reviews, and has particular interests in pituitary and hypothalamic tumours, endocrine oncology, and the molecular pathogenesis of neuroendocrine tumours. He is President of the European Neuroendocrine Association, and on the editorial board of many journals, having previously been Senior Editor of Clinical Endocrinology. He is married with 6 daughters who occupy most of his time when he is not working. He visited the Department on January 2007.
  
     
  Prof. Bernd Scheithauer  
 
Bernd Scheithauer is a consultant in pathologist in the Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. A world renowned neuropathologist, Dr Scheithauer completed his training in Neuropathology from the Stanford University under the guidance of one of the pioneers in this field Luci J Rubinstein.
 
  Dr Scheithauer joined Mayo College of Medicine in 1979 and has been one of the most respected members of the faculty of this reputed institution ever since.  
           His skillful diagnostic abilities stem from a keen eye for detail and a thorough understanding of neurobiology. His vast experience in Neuropathology makes him a walking atlas of different morphologic patterns that one can see in Neuropathology. A morphologist at heart BWS has not shunned the advances in molecular Neuropathology, but has found a good balance between the two, using information gathered from molecular tests on occasion to complement his interpretation of a case.  
           BWS is a passionate and superb teacher - the constant stream of visiting pathologist training under his guidance at Mayo are a testament to this fact. A prolific writer he has more than 600 articles, and more than 60 chapters on various topics related to Neuropathology to his credit. In addition he has edited and co-authored several textbooks in Neuropathology. His research interests are in the classification and pathobiology of brain, pituitary and peripheral nerve tumors. He visited the Department on January 2001.  
     
  Prof. Bernie Tuch  
 
Professor Bernie Tuch is the Director of the Diabetes Transplant Unit at Prince of Wales Hospital and The University of New South Wales in Sydney, Australia. He is a senior staff specialist in endocrinology. His Unit is on the cutting edge of research into replacing the missing insulin-producing cells as a treatment of type 1 diabetes. Such treatments include
 
 
novel approaches, such as placing insulin-producing cells from donor human pancreases inside capsules to prevent rejection when transplanted and creating human embryonic stem cells to differentiate them into insulin-producing cells. Support is forthcoming from national and international peer-reviewed grants, industry and private sources. Professor Tuch directs the New South Wales Stem Cell Network, a group of 500 professionals interested in stem cells and their applications.Internationally, he is a Councillor for the Cell Transplant Society. During the three decades of his research he has produced 126 manuscripts in refereed journals, written 11 book chapters and 1 book. He visited the Department on January 2007.
 
     
  C.B. Sanjeevi MD ,Msc PhD  
 
CURRENT POSITION:
Associate Professor, Karolinska Institute, Division of Diabetes and Endocrinology, Department of Molecular Medicine
Head, Molecular Immunogenetics Group, Center for Molecular Medicine, Karolinska Hospital, Stockholm
 
  Karolinska Institute's Scientific Coordinator for India  
  Assignments:  
  Member of the Council of European Association for the Study of Diabetes (EASD since 2003  
  Member of the Genetics committee of the TRIAL NET of USA. Trialet is a network of individual scientists who work together in evaluating protocols and research plans submitted by various researchers for conduction human clinical trials for the Prevention of Type 1 diabetes, post diabetes prevention trial 1 (DPT-1).  
         Member of the Type 1 Diabetes Genetics Consortium (T1DGC) supported by NIH (USA) and JDRF (USA). The aim of the T1DGC is to collect T1DM families from all over the world for genome wide scanning of diabetes susceptibiity genes. I am in-charge of collecting families from South Asia. He visited the Department on September 2006.  
     
  Dr. Saudek  
 
Dr. Saudek graduated from Harvard College and Cornell University Medical College, training in metabolism at Boston City Hospital, Harvard Unit, followed by a fellowship in metabolism at Harvard Medical School. Dr. Saudek joined the faculty of Johns Hopkins University School of Medicine where he is currently the Hugh P. McCormick Family Professor of Medicine,
 
 
Director of the Johns Hopkins Diabetes Center and Program Director of the General Clinical Research Center. At Johns Hopkins, Dr. Saudek teaches students at all levels. He sees patients regularly, and lectures on various aspects of diabetes. He founded the Johns Hopkins Diabetes Center, a patient education program, and authored The Johns Hopkins Guide to Diabetes: for Today and Tomorrow (JHU Press). His research has focused on the development of the implantable insulin pump. He is principal investigator of the Hopkins center for the Diabetes Prevention Program (DPP), and of a Training Grant in Diabetes and Endocrinology, and other research grants. The NIH has continuously funded Dr. Saudek since 1975.
  
 
       Dr. Saudek has been active in professional organizations, and was President of the American Diabetes Association in 2001-2, and named Outstanding Clinician in Diabetes by the ADA in 1990. He visited the Department on January 2007.
  
     
  Dr. Christopher White  
 
Consultant Endocrinologist
  Department of Endocrinology,
  South Eastern Area Laboratory Services (SEALS),
  Prince of Wales Hospital,
  Level 4, Campus Centre, Barker Street,
  Randwick NSW 203
  Interets: Osteoporosis and Metaolic Bone Disease. He visited the Department on January 2007.
 
     
  Dr. Fredrik Karpe, PhD, FRCP Reader in Metabolic Medicine  
 
Fredrik Karpe is a Welcome Trust senior clinical research fellow and an honorary consultant physician at Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Oxford UK. The focus of Dr Karpe's research is on human lipid and carbohydrate metabolism using integrative physiological and genomic approaches to understand the metabolic and cardiovascular complications of obesity and type 2 diabetes.
 
  A particular interest is the development and adoption of techniques for tissue-specific study of metabolic and physiological processes in vivo in humans. This often involves stable isotope tracer studies in combination with genomic/genetic approaches, sometimes using pharmacological agents to investigate tissue-specific metabolism and functional studies of human adipose tissue in vivo. Some of these studies are enabled by the establishment of the Oxford Biobank, which is a population-based screening of healthy participants in Oxfordshire allowing for a "recruit-by-genotype" approach. Dr Karpe's research is funded by the Wellcome Trust, British Heart Foundation and Diabetes UK. Dr Karpe is a member of the editorial boards of three international journals: 1. Atherosclerosis, 2. Nutrition, Metabolism and Cardiovascular disease and 3. International Journal of Obesity. His is President-Elect for the Royal Society of Medicine section on Lipids in Clinical Medicine. He visited the Department on January 2006.
  
     
  Dr. George P. Chrousos, MD  
 
Dr. Chrousos is Professor and Chairman of Pediatrics at the Athens University Medical School. He has focused his research on the hypothalamic-pituitary-adrenal (HPA) axis and has extensively studied the neuroendocrine alterations associated with mood disorders, sleep, pain perception, and immune function.
 
  His laboratory is recognized worldwide for its work on the glucocorticoid signaling system, diseases of the HPA axis, such as Cushing’s syndrome, and the physiologic and molecular mechanisms of stress. Dr. Chrousos has contributed immensely to the biomedical literature and his work has provided new insights into a variety of chronic complex disorders. He has written over 1000 scientific papers and his work has been cited in over 40,000 other scientific articles, an irrefutable testimony to the importance and influence of his research. He is one of the most cited physician scientists in the world (ISI highly cited) both in Clinical Medicine and in Biology and Biochemistry. His work has educated a broad community of physicians and scientists around the world. As a mentor, he has helped to develop the careers of many young physicians and scientists, several of whom are now professors and chairpersons in Europe, the United States, Australia and Latin America. An oustanding teacher, he has had a number of visiting professorships and given prestigious lectures throughout the world. Dr. Chrousos has received numerous national and international awards for his work, including election to membership in the prestigious American Society of Clinical Investigation and the Association of American Physicians. He was recently inducted as a master of both the American College of Endocrinology and the American College of Physicians. He visited the Department on January 2007.  
     
  Iskandar Idris  
 
Dr Iskandar Idris is a Consultant in Diabetes, Endocrinology and Internal medicine for the Sherwood Forest Hospitals NHS Trust, UK.
Dr Idris is currently a member of the EASD-Hypertension in Diabetes Study group, and is also in the steering committee for the implementation of the North Nottinghamshire Diabetic Retinopathy screening programme.
 
  His current research interests are in cardiovascular risks in patients with diabetes, the metabolic syndrome and pharmacological treatment for hyperglycaemia and vascular complications of diabetes. He has published widely in the field of diabetes and vascular complications. He visited the Department on January 2007.  
     
  J J Mukherjee MD, FAMS, FRCP  
 
Dr. Mukherjee is a Consultant Endocrinologist in the Department of Medicine at the National University Hospital (NUH), Singapore and a Clinical Lecturer in the Faculty of Medicine, National University of Singapore. His chief clinical interests are in pituitary & adrenal disorders, endocrine hypertension, and neuroendocrine tumours.
He is in the specialist advisory panel of the Annals, Academy of Medicine, Singapore, is an
 
  active member of a number of administrative committees in NUH, and is an executive committee member of the Endocrine and Metabolic Society of Singapore. He visited the Department on January 2007.  
     
  Prof. Kalman Kovacs  
 
Kalman Kovacs obtained his MD degree from the Medical University of Szeged, Szeged, Hungary. As a medical student, he started to be involved in research in the Department of Pathology, University of Szeged. After graduating, he continued to work at the same department and performed research, autopsy and surgical pathology. After a few years, he moved to the Department of Medicine
 
  and was trained as a clinical endocrinologist. He received a fellowship from the University of Liverpool, Liverpool, England. Under the supervision of Dr. H.L. Sheehan, a world renowned and respected scientist and pathologist, he received his Ph.D. degree. In 1968 he was invited to Canada as a visiting scientist to carry out research at the Department of Experimental Medicine and Surgery, University of Montreal. The Department Head was Dr. H. Selye, a superb researcher. In 1971, Dr. Kovacs moved to Toronto and as a staff pathologist, worked at the Department of Pathology, St. Michael’s Hospital, a major teaching hospital of the University of Toronto. In 1980, he was promoted to the rank of Professor of Pathology.  
         Dr. Kovacs’ main interest is endocrine pathology, primarily pathology of the pituitary gland and its tumours. He has published many papers, book chapters and books. He is the founding editor of the journal: Endocrine Pathology. He is an editorial board member of several journals and associate editor of the journal: Pituitary. He is a member of the Canadian, American and British Pathology Societies. He has lectured at many local, national and international meetings, chaired sessions and organized several symposia. Dr. Kovacs has received several awards, has supervised many students, researchers and post-doctoral fellows.  
 
       His contributions are internationally recognized and respected, making him a leader in pituitary pathology. He visited the Department on January 2001.
 
     
  Professor K O Lee  
 
Professor K O Lee is Professor and Head of Endocrinology at the Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, and National University Hospital, Singapore. He graduated in Medicine from the Queen's University of Belfast, Northern Ireland and eventually came to work in the National University in Singapore. In addition to his training in Belfast, he has spent time at the National Institutes of Health in Bethesda, and at Stanford University.
 
  His primary research focus is on the growth hormone (GH) - insulin like growth factor (IGF)- IGF binding protein axis; but has clinical responsibilities as Head of Endocrinology in most of the other areas of Non-Diabetes endocrinology at the National University Hospital. He has published 80 papers in peer-reviewed journals.  
 
       His previous administrative and Professional positions include - President of the Endocrine and Metabolic Society of Singapore, Chairman of the Chapter of Physicians in the Academy of Medicine, Singapore, and Chairman of the Endocrinology Advanced Training Committee in Singapore. He is an Editor of the J AFES (Journal of the ASEAN Federation of Endocrine Societies) and Review of Endocrinology. He visited the Department on January 2007.
  
     
  Dr Marie-France Kong  
 
Dr Marie-France Kong is a consultant in Diabetes & Endocrinology at the University Hospitals of Leicester, United Kingdom. She graduated from Aberdeen medical school and did her postgraduate training in the West Midlands and in Nottingham. She did her research on "gastric emptying and glycaemic control in diabetes mellitus" in Nottingham
 
  with Professors Tattersall and Macdonald and in Adelaide, South Australia, with Professor Michael Horowitz. Other research interests include pregnancy and diabetes, complications of diabetes and cardiometabolic syndrome. Dr. Kong is a contributing editor for the Continuing Education section of Diabetic Medicine. She visited the Department on January 2007.  
     
  Prof Michael Horowitz  
 
Prof Michael Horowitz was appointed to a Personal Chair at the University of Adelaide in 1995, and has been the Director of the Endocrine and Metabolic Unit at the Royal Adelaide Hospital since 1997. His research activities are almost exclusively clinically-based and relate primarily to gastrointestinal motor, sensory, and hormonal function,
 
  particularly in the context of diabetes mellitus, glycaemic control, and appetite regulation. Prof Horowitz is a co-author of 401 peer-reviewed papers and 32 book chapters, placing him in the top 1% of cited authors in clinical medicine world-wide. He is co-editor (with Prof Melvin Samsom) of a multi-author book entitled ‘Gastrointestinal function in diabetes mellitus’, published in 2004, which represents the most comprehensive treatise on this subject. Prof Horowitz has had extensive involvement as an invited speaker at international and scientific meetings, including the annual meetings of the American Diabetes Association, American Gastroenterological Association, European Association for the Study of Diabetes and American Motility Society. The insights derived from his work have been of fundamental relevance to the management of diabetes in the spheres of both prevention and treatment. He has been the recipient of a number of awards, including the Elder Prize for Scholarship at the University of Adelaide in 1995, the Distinguished Research Prize of the Gastroenterological Society of Australia (1999), and the Eric Susman Prize of the Royal Australasian College of Physicians (2000). Prof Horowitz has supervised 29 PhD or MD candidates from medical, science, nuclear medicine, nursing and dietetic backgrounds, and 11 postdoctoral research fellows (from the UK, the Netherlands, Germany, and Singapore). He visited the Department on January 2007.  
     
  Dr. Noel Somasundaram  
 
Chief Consultant Endocrinologist, National Hospital of Sri Lanka
Became the first board certified endocrinologist of Sri Lanka and holding post as Chief Consultant Endocrinologist, National Hospital of Sri Lanka. Currently Secretary, Endocrine Society of Sri Lanka and in the editorial board of the Journal of the Ceylon College of Physicians. One of the 3 steering committee members that oversee the Task Force for Prevention of Diabetes in Sri Lanka. He visited the Department on January 2007.
 
     
  Dr. Prakash Abraham  
 
Consultant Endocrinologist at the Aberdeen Royal Infirmary (and Honorary Senior Lecturer at the University of Aberdeen). He is the current secretary of the British Thyroid Association and is on the programme organising committee of the UK Society for Endocrinology. In Diabetes he is the local lead for insulin pump therapy and is the local principal investigator for several multicenter diabetes clinical trials. He visited the Department on January 2007.
 
     
  Prof. Rury Holman, FRCP  
 
(Professor of Diabetic Medicine, Diabetes Trials Unit, The Oxford Centre for Diabetes, Endocrinology and Metabolism)
Rury Holman is Professor of Diabetic Medicine at the University of Oxford, Academic Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM),
 
 
Director of the Diabetes Trials Unit, and an Honorary Consultant Physician to the Oxford Radcliffe Hospitals Trust. He was the 2002 Pfizer Visiting Professor at the University of Washington, gave the 2003 Lord Rayner Memorial Lecture and was awarded the 2006 Hellmut Mehnert Award. He divides his time between the clinical care of patients, teaching and his many research interests. He has designed and run many multicentre studies that focus primarily on the prevention and appropriate treatment of Type 2 diabetes. Professor Holman, who is asked frequently to speak at international meetings, has published over 250 peer-reviewed papers, is co-chair of the NAVIGATOR and DREAM trials and principal investigator of AFORRD, 4-T and the UK Prospective Diabetes Study (UKPDS). He visited the Department on January 2007.
 
     
  Prof. Stephen Colagiuri  
 
Director, Department of Endocrinology,
Diabetes and Metabolism Proor,
Faculty of Medicine,
University of New South Wales.
Member Australian Government National Diabetes Strategy Group
Past President Australian Diabetes Society
 
  Research interests include:  
    Evidence based systems and standards of diabetes care  
    Guideline implementation and models of diabetes care  
    Screening for Type 2 diabetes  
    Economic aspects of diabetes. He visited the Department on January 2002.  
     
  Professor Chatterjee  
 
Professor Chatterjee graduated from Cambridge and completed his clinical training at Oxford Medical School. He trained as an Endocrinologist at the Hammersmith Hospital, London and subsequently conducted research in the Thyroid Unit at Massachusetts General Hospital, Boston. In 1990, he returned to the Department of Medicine in Cambridge and
 
  was appointed Professor of Endocrinology in 1998. His research interests include nuclear hormone receptors (thyroid, PPAR?) and human disease, genetic thyroid disorders and hormone replacement in adrenal insufficiency. He visited the Department on January 2007.